Drug profile · INN
dexbrompheniramine maleate
BROMPHERIL
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
dexbrompheniramine maleate (BROMPHERIL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN dexbrompheniramine maleate
Brand BROMPHERIL
Route ORAL
Formulation TABLET
Frequently asked questions
What is dexbrompheniramine maleate?
dexbrompheniramine maleate (BROMPHERIL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dexbrompheniramine maleate?
BROMPHERIL is a marketed brand name for dexbrompheniramine maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dexbrompheniramine maleate?
dexbrompheniramine maleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.